BAZELET™
Investor Relations
Investing in Legal Cannabis
Meet Mr. Tareen, he is here to help!
Investor relations manager Amjad Tareen communicates the company’s results, strategy and plans to everyone with an interest in its development – not only the company’s shareholders, but also its employees and management, as well as external market analysts. We are responsible for ensuring that the information shared with people outside the company is relevant, factually correct, timely and understandable. We also have a duty to ensure that our stocks are marketed in the right way to the right investors and potential investors, and that our internal management know what effects their actions are having on the business.
Socially Responsible Investing
News and more. . .
Shareholders’ Meeting
Shareholders’ Meeting on Thursday, July 21, 1 PM Eastern Time. General Update and Q&A Zoom link: https://bit.ly/3yVm31c Password: 410089 Or Telephone: Dial:+1 301 715 8592
Subscription with OTC Markets Suspended
Dear All, As a result of negligible trading activity, a negative return on investment, a low percentage of OTCMarkets.com success, and the notion that the
Bazelet™ to Supply Its Federally Legal Cannabis Genetics to DEA Approved Research Entities for Rigorous Scientific Research on the Clinical Effects of Cannabigerol (CBG)
COLUMBIA, Md., June 07, 2022 (GLOBE NEWSWIRE) — Neon Bloom, Inc. (OTC: NBCO): Bazelet Health Systems™, a wholly-owned subsidiary of Neon Bloom, is proud to
Advancing the global expanding use of cannabis-zero™
SUSTAINABILITY, FOR GOODNESS SAKE
Investor Resources and Information
Contact Bazelet™ Team
Newsletter
Investor.gov
International Production Capabilities & Global Market Scope
Shareholders’ Meeting
Shareholders’ Meeting on Thursday, July 21, 1 PM Eastern Time. General Update and Q&A Zoom link: https://bit.ly/3yVm31c Password: 410089 Or Telephone: Dial:+1 301 715 8592
Subscription with OTC Markets Suspended
Dear All, As a result of negligible trading activity, a negative return on investment, a low percentage of OTCMarkets.com success, and the notion that the
Bazelet™ to Supply Its Federally Legal Cannabis Genetics to DEA Approved Research Entities for Rigorous Scientific Research on the Clinical Effects of Cannabigerol (CBG)
COLUMBIA, Md., June 07, 2022 (GLOBE NEWSWIRE) — Neon Bloom, Inc. (OTC: NBCO): Bazelet Health Systems™, a wholly-owned subsidiary of Neon Bloom, is proud to
Bazelet™ to Introduce its PECSA™ Ingredient at the National Restaurant Association Show May 21-24, 2022, Chicago, IL.
May 06, 2022, 06:00 ET | Source: Bazelet Health Systems, Inc. COLUMBIA, Md., May 06, 2022 (GLOBE NEWSWIRE) — Neon Bloom Inc. (OTC: NBCO): Bazelet Health Systems,
Bazelet Health Announces a U.S. Scientific Achievement and Scientific Proof of Cannabis America™, its 0% THC Tri-Purpose Cannabis Plant for Global Markets.
Neon Bloom Inc. (OTC: NBCO) April 28, 2022, Columbia, Maryland: Bazelet Health Systems, Inc. (Bazelet™), a wholly-owned subsidiary of Neon Bloom Inc., announces that its Cannabis
Financials Opportunity
Press
Shareholders’ Meeting
Shareholders’ Meeting on Thursday, July 21, 1 PM Eastern Time. General Update and Q&A Zoom link: https://bit.ly/3yVm31c Password: 410089 Or Telephone: Dial:+1 301 715 8592
Subscription with OTC Markets Suspended
Dear All, As a result of negligible trading activity, a negative return on investment, a low percentage of OTCMarkets.com success, and the notion that the
Bazelet™ to Supply Its Federally Legal Cannabis Genetics to DEA Approved Research Entities for Rigorous Scientific Research on the Clinical Effects of Cannabigerol (CBG)
COLUMBIA, Md., June 07, 2022 (GLOBE NEWSWIRE) — Neon Bloom, Inc. (OTC: NBCO): Bazelet Health Systems™, a wholly-owned subsidiary of Neon Bloom, is proud to
